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Click chemistryAbstract Four gluco-triazole conjugates were synthesized employing Cu(I) catalyzed click reac-
tions between peracetylated glucosyl azide and alkyl-(propynoxy)ethyl-triazoles which in turn were
prepared under similar reaction conditions using the appropriate alkyl azide (C7, C8, C10, and C12)
and but-3-yn-1-ol. Removal of the acetyl protecting groups afforded additional four compounds.
All eight conjugates were assessed toward inhibition of bacterial growth (Escherichia coli,
Staphylococcus aureus). Slight growth inhibition compared to kanamycin was observed at a
concentration of 20 lg/mL, while no growth inhibition was observed at the lowest concentration
(5 lg/mL).
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Cu(I) catalyzed cycloaddition reactions are called click reac-
tions (Hein and Fokin, 2010). Forming substituted triazole
system has created a wide range of applications (Binder and
Sachsenhofer, 2007; Kolb and Sharpless, 2003; Evans, 2007;
Francis et al., 2011; Nenajdenko et al., 2010; Rathwell
et al., 2010; Wan et al., 2006; Whiting et al., 2006). As it
has been shown in many works, signiﬁcant sugar based
1,2,3-triazole derivatives have been synthesized (Mohammed+964 7906487332, +964
.com (A.I. Mohammed).
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mmed, A.I. et al., Synthesis and a
iazolesd-glucose –>. Arabian Journet al., 2012; Jwad, 2011; Ali et al., 2009). As a result, a number
of 1,2,3-triazoles have been synthesized regarding click condi-
tions using microwave irradiation and the biological activities
of the prepared compounds were monitored against different
types of microorganisms (Mohammed et al., 2010) and were
observed for their important behavior toward bacteria and
fungi. Recently, biologically interesting tetrakis-1,2,3-triazoles
starting from D-mannitol utilizing the copper catalyzed ‘click’
protocol were synthesized and the antibacterial activity was
measured in vitro (Mohammed et al., 2013), in addition; these
triazole derivatives showed a signiﬁcant antibacterial activity.
Many other examples showed the importance of the synthe-
sized 1,2,3-triazole derivatives as antimicrobial agents
(Dharshan et al., 2012; Gautam and Chourasia, 2012). 1,2,3-
Triazoles containing quinoline moiety presented a broad spec-
trum of antifungal activity (Sumangala et al., 2010). Moreover,
a series of synthesized 1,2,3-triazolphanes exhibited both
antifungal and antibacterial activities (Lal et al., 2013). Adding
to this, glycal-derived 1,2,3-triazoles appeared to resembleier B.V. All rights reserved.
ntibacterial activity of 1-N-(b-D-glucopyranosyl)-4-((1-substituted-1H-
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2 A.I. Mohammed et al.antimicrobial activity (Reddy et al., 2010). This paper
describes the synthesis of new ether-linked bis-1,2,3-triazole
derivatives based on D-glucose and the measurement of the
antibacterial activity of these derivatives in vitro against the
Escherichia coli () and Staphylococcus aureus (+). (See
Fig. 1 and Scheme 1.)
2. Experimental section
2.1. General experimental information
All chemicals and solvents were obtained from commercial
sources and were used without further puriﬁcation. Optical
rotations were determined at the sodium D line at 25 C. Infra-
red spectra were recorded using SHIMADZU 2001 FT-IR.
Routine 1H and 13C NMR spectra were obtained on a Bruker
spectrometer DPX 300 (300 MHz for 1H NMR and 75 MHz
for 13C NMR, respectively) or on a Bruker Avance III 400
spectrometer (400 MHz for 1H NMR and 100 MHz for 13C
NMR, respectively). Chemical shifts were recorded in parts
per million (ppm) relative to solvent nuclei as an internal ref-
erence. HRMS spectra were recorded on a Thermo LTQ FT
mass spectrometer. Puriﬁcation of the crude products by
column chromatography was performed on silica gel 60
(230–400 mesh, 0.040–0.063 mm). Silica TLC plates were used
with an aluminum backing (0.2 mm, 60 F254). The reactions
were monitored by TLC and visualized by the development
of the TLC plates with an alkaline potassium permanganate
dip. The antibacterial activity was determined using the agar
well diffusion method.
2.2. Synthesis
2.2.1. General procedure for synthesis of 1,2,3-triazol-4-yl
alcohols (2a–d)
A solution of but-3-yn-1-ol (7.0 mmol) in DMSO (3 mL) was
added dropwise to the suspension of sodium ascorbate
(0.13 g, 0.63 mmol) and CuSO4.5H2O (0.077 g, 0.35 mmol) in
DMSO (2 mL). The mixture was stirred for few minutes and
to this was added the suitable n-alkyl azide (7.0 mmol) then
it was stirred at 50 C for 36 h. The reaction mixture was di-
luted with distilled water (70 mL), extracted with EtOAc
(3 · 60 mL), the combined organic layers were washed with
sat. NaCl (2 · 20 mL), dried over Na2SO4, and evaporated
to dryness under reduced pressure. The residue was ﬂash chro-
matographed (silica gel, 3:1 to 1:2 n-hexane: Et2O) to yield the
desired 1,2,3-triazol-4-yl alcohols 2a–d.O
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1,2, 3-triazol-4-yl)ethoxymethyl)-1,2,3-triazolesd-glucose –>. Arabian Journ2.2.1.1. 2-(1-Heptyl-1H-1,2,3,-triazol-4-yl)ethanol (2a). White
solid (1.36 g, 92%), mp 50–52 C; (CAS number 1249705–13-
2), Rf = 0.17 (n-hexane/EtOAc 1:1), IR (KBr): 3433, 3257,
3134, 3080, 2954, 2926, 2852, 1462, 1373, 1215, 1145, 1058,
1020, 831, 729, 675 cm1. 1H NMR (400 MHz, CDCl3) d
ppm: 0.84 (t, J 6.8 Hz, 3H, H70), 1.26 (m, 8H, H30-H60), 1.85
(quin, J 7.4 Hz, 2H, H20), 2.91 (t, J 6.0 Hz, 2H, C4triazoleA
CH2ACH2AOH), 3.13 (broad s, 1H, AOH), 3.90 (t, J
6.0 Hz, C4triazoleACH2ACH2AOH), 4.28 (t, J 7.3 Hz, 2H,
H10), 7.37 (s, 1H, H5) .13C NMR (100 MHz, CDCl3) d ppm:
14.1, 22.6, 26.5, 28.7, 28.8, 30.4, 31.6, 50.4, 61.6, 121.5,
145.5; HRMS (ESI) calcd for C11H22N3O 212.1756
[M+ H]+, found 212.1757.
2.2.1.2. 2-(1-Octyl-1H-1,2,3,-triazol-4-yl)ethanol (2b). White
solid (1.48 g, 94%), mp 53–54 C (waxy solid, Nulwala et al.,
2009); Rf = 0.16 (n-hexane/EtOAc 1:1), IR (KBr): 3261,
3138, 3084, 2951, 2924, 2854, 1458, 1371, 1217, 1145, 1056,
1022, 829, 732, 678 cm1. 1H NMR (400 MHz, CDCl3) d
ppm: 0.86 (t, J 6.7 Hz, 3H, H80), 1.27 (m, 10H, H30AH70),
1.87 (quin, J 7.4 Hz, 2H, H20), 2.67 (broad s, 1H, AOH),
2.94 (t, J 5.8 Hz, 2H, C4triazoleACH2ACH2AOH), 3.93 (t, J
5.9 Hz, C4triazoleACH2ACH2AOH), 4.30 (t, J 7.3 Hz, 2H,
H10), 7.37 (s, 1H, H5) .13C NMR (100 MHz, CDCl3) d ppm:
14.2, 22.7, 26.6, 28.8, 29.1, 29.14, 30.4, 31.8, 50.4, 61.8,
121.5, 145.6; HRMS (ESI) calcd for C12H23N3ONa 248.1733
[M+ Na]+, found 248.1731.
2.2.1.3. 2-(1-Decyl-1H-1,2,3,-triazol-4-yl)ethanol (2c). White
solid (1.60 g, 90%), mp 56–58 C; (CAS number 1457635–78-
7) Rf = 0.15 (n-hexane/EtOAc 1:1), IR (KBr): 3258, 3138,
3084, 2949, 2922, 2850, 1458, 1371, 1215, 1145, 1066, 1020,
833, 729, 678 cm1. 1H NMR (400 MHz, CDCl3) d ppm:
0.85 (t, J 6.8 Hz, 3H, H100), 1.29 (m, 14H, H30AH90), 1.86
(quin, J 7.4 Hz, 2H, H20), 2.92 (t, J 6.0 Hz, 2H, C4triazoleA
CH2ACH2AOH), 3.00 (broad s, 1H, AOH), 3.91 (t, J
6.0 Hz, C4triazole ACH2ACH2AOH), 4.28 (t, J 7.3 Hz, 2H,
H10), 7.37 (s, 1H, H5) .13C NMR (100 MHz, CDCl3) d ppm:
14.2, 22.7, 26.6, 28.8, 29.1, 29.3, 29.5, 29.53, 30.4, 31.9, 50.4,
61.7, 121.5, 145.5; HRMS (ESI) calcd for C14H27N3ONa
276.2046 [M+ Na]+, found 276.2044.
2.2.1.4. 2-(1-Dodecyl-1H-1,2,3,-triazol-4-yl)ethanol (2d).
White solid (1.73 g, 88%), mp 67–69 C (67–68 C, Sabbah
et al., 2012); Rf = 0.15 (n-hexane/EtOAc 1:1), IR (KBr):
3257, 3136, 3066, 2920, 2850, 1458, 1371, 1215, 1145, 1058,
1022, 833, 727, 678 cm1. 1H NMR (400 MHz, CDCl3) d
ppm: 0.85 (t, J 6.7 Hz, 3H, H120), 1.27 (m, 18H, H30AH110),NN
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Scheme 1 The synthetic route of D-glucose based bis-1,2,3-triazoles.
Synthesis of new ether-linked bis-1,2,3-triazole derivatives based on D-glucose 31.87 (quin, J 7.2 Hz, 2H, H20), 2.92 (t, J 6.0 Hz, 2H, C4triazoleA
CH2ACH2AOH), 3.01 (broad s, 1H, AOH), 3.91 (t, J 6.0 Hz,
C4triazoleACH2ACH2AOH), 4.28 (t, J 7.3 Hz, 2H, H10), 7.37
(s, 1H, H5) .13C NMR (100 MHz, CDCl3) d ppm: 14.2, 22.8,
26.6, 28.8, 29.1, 29.4, 29.5, 29.6, 29.67, 29.7, 30.4, 32.0, 50.4,
61.7, 121.5, 145.5; HRMS (ESI) calcd for
C16H31N3ONa 304.2359 [M+Na]
+, found 304.2358.
2.2.2. General procedure for synthesis of alkynyl triazoles (3a–
d)
Triazolyl alcohol 2 (4 mmol) was dissolved in DMF (15 mL)
and NaOH pellets (0.6 g, 15 mmol) were added. The mixture
was cooled in ice-salt bath to 20 C and the contents were
stirred vigorously for 10 min and then propargyl bromide
(0.4 mL, 4.3 mmol) was added drop wise. The heterogeneous
reaction mixture was stirred vigorously for 24 h, slowly
warming to room temperature. The mixture was ﬁltered and
H2O (50 mL) was added and the product was extracted with
Et2O (4 · 50 mL). The organic phases were combined and
washed sequentially with 5% HCl (2 · 50 mL) and distilled
water (50 mL). The organic phase was dried over Na2SO4,
ﬁltered and the solvent was evaporated to dryness under
reduced pressure to yield a residue which was ﬂash chromato-
graphed (silica gel, 9:1 to 1:1 n-hexane: Et2O) to afford the
alkynyl triazoles 3a–d.
2.2.2.1. 1-Heptyl-4-(2-(prop-2-yn-1-yloxy)ethyl)-1H-1,2,3-tri-
azole (3a). Pale yellow oil (0.86 g, 86%); Rf = 0.25 (n-hexane/
EtOAc 1:1), IR (neat): 3226, 3082, 2954, 2929, 2860, 2113,
1456, 1361, 1217, 1101, 1053, 950, 912, 802, 715, 667 cm1.
1H NMR (400 MHz, CDCl3) d ppm: 0.81 (t, J 6.8 z 3H,
H70), 1.24 (m, 8H, H30AH60), 1.83 (quin, J 7.2 Hz, 2H, H20),
2.38 (t, J 2.4 Hz, 1H, OACH2AC„CH), 2.97 (t, J 6.5 Hz,
2H, C4triazoleACH2ACH2AO), 3.75 (t, J 6.5 HZ, 2H, C4triazole
ACH2ACH2AO), 4.11 (d, J 2.4 Hz, 2H, OACH2AC„CH),
4.25 (t, J 7.2 Hz, 2H, H10), 7.36 (s, 1H, H5) .13C NMR
(100 MHz, CDCl3) d ppm: 14.0, 22.5, 26.4, 26.43, 28.7, 30.3,
31.6, 50.2, 58.1, 68.9, 74.5, 79.7, 121.6, 144.8; HRMS (ESI)
calcd for C14H23N3ONa 272.1733 [M+ Na]
+, found
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zole (3b). Pale yellow oil (0.90 g, 85%); Rf = 0.25 (n-hexane/
EtOAc 1:1), IR (neat): 3292, 3078, 2956, 2922, 2850, 2115,
1462, 1369, 1145, 1107, 1058, 952, 912, 825, 725, 671 cm1.
1H NMR (400 MHz, CDCl3) d ppm: 0.87 (t, J 6.8 z 3H,
H80), 1.27 (m, 10H, H30AH70), 1.88 (quin, J 7.3 Hz, 2H,
H20), 2.42 (t, J 2.4 Hz, 1H, OACH2AC„CH), 3.02 (t, J
6.5 Hz, 2H, C4triazole ACH2ACH2AO), 3.80 (t, J 6.5 HZ,
2H, C4triazoleACH2ACH2AO), 4.20 (d, J 2.4 Hz, 2H, OACH2-
AC„CH), 4.30 (t, J 7.2 Hz, 2H, H10), 7.39 (s, 1H, H5) .13C
NMR (100 MHz, CDCl3) d ppm: 14.2, 22.7, 26.5, 26.6, 29.1,
29.2, 30.5, 31.8, 50.4, 58.3, 69.1, 74.6, 79.8, 121.7, 145.0;
HRMS (ESI) calcd for C15H25N3ONa 282.1889 [M+ Na]
+,
found 282.1885.
2.2.2.3. 1-Decyl-4-(2-(prop-2-yn-1-yloxy)ethyl)-1H-1,2,3-tria-
zole (3c). Waxy solid (0.99 g, 85%), mp 40–42 C; Rf = 0.24
(n-hexane/EtOAc 1:1), IR (KBr): 3292, 3076, 2922, 2854,
2115, 1552, 1458, 1365, 1145, 1217, 1105, 1043, 952, 910,
825, 725, 669, 634 cm1. 1H NMR (300 MHz, CDCl3) d
ppm: 0.86 (t, J 6.5 z 3H, H100), 1.29 (m, 14H, H30AH90),
1.87 (broad quin, J 7.1 Hz, 2H, H20), 2.41 (t, J 2.5 Hz, 1H,
OACH2AC„CH), 3.02 (t, J 6.5 Hz, 2H, C4triazoleA
CH2ACH2AO), 3.80 (t, J 6.5 HZ, 2H, C4triazoleACH2A
CH2AO), 4.16 (d, J 2.4 Hz, 2H, OACH2AC„CH), 4.29 (t, J
7.2 Hz, 2H, H10), 7.38 (s, 1H, H5) .13C NMR (75 MHz,
CDCl3) d ppm: 14.2, 22.8, 26.5, 26.6, 29.1, 29.4, 29.5, 29.6,
30.4, 32.0, 50.3, 58.3, 69.1, 74.6, 79.9, 121.6, 145.0; HRMS
(ESI) calcd for C17H29N3ONa 314.2203 [M+ Na]
+, found
314.2198.
2.2.2.4. 1-Dodecyl-4-(2-(prop-2-yn-1-yloxy)ethyl)-1H-1,2,3-
triazole (3d). Pale yellow oil (1.0 g, 80%), mp 47–49 C;
Rf = 0.22 (n-hexane/EtOAc 1:1), IR (KBr): 3292, 3078,
2954, 2922, 2850, 2115, 1554, 1462, 1365, 1215, 1145, 1107,
1060, 952, 912, 825, 725, 669, 632 cm1. 1H NMR
(400 MHz, CDCl3) d ppm: 0.86 (t, J 6.8 z 3H, H120), 1.29
(m, 18H, H30AH110), 1.86 (broad quin, J 6.9 Hz, 2H, H20),
2.41 (t, J 2.4 Hz, 1H, OACH2AC„CH), 3.01 (t, J 6.5 Hz,
2H, C4triazoleACH2ACH2AO), 3.80 (t, J 6.5 HZ, 2H, C4triazole-ntibacterial activity of 1-N-(b-D-glucopyranosyl)-4-((1-substituted-1H-
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4 A.I. Mohammed et al.ACH2ACH2AO), 4.20 (d, J 2.4 Hz, 2H, OACH2AC„CH),
4.29 (t, J 7.2 Hz, 2H, H10), 7.38 (s, 1H, H5) .13C NMR
(100 MHz, CDCl3) d ppm: 14.2, 22.8, 26.5, 26.6, 29.1, 29.4,
29.5, 29.6, 29.8, 30.5, 32.0, 50.4, 58.3, 69.1, 74.6, 79.8, 121.7,
145.0; HRMS (ESI) calcd for C19H33N3ONa 342.2516
[M+Na]+, found 342.2511.
2.2.3. General procedure for synthesis of bistriazoles (4a–d)
Alkynyl triazole 3 (1.0 mmol) and 2,3,4,6-tetra-O-acetyl-b-
D-glucopyranosyl azide were added to the suspension of
sodium ascorbate (0.018 g, 0.09 mmol) and CuSO4.5H2O
(0.011 g, 0.045 mmol) in DMSO (5 mL). The mixture was
stirred at 70 C for 48 h. After which, it was diluted with
water (30 mL), extracted with EtOAc (3 · 30 mL) and the
combined organic layers were washed with brine
(2 · 20 mL), dried over Na2SO4 and evaporated to dryness
under reduced pressure. The residue was ﬂash chromato-
graphed (silica gel, 3:1 to 1:2 EtOAc/n-hexane) to yield
the desired compounds 4a–d.
2.2.3.1. 1-N-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-4-
(((1-n-heptyl-1H-1,2,3-triazol-4-yl)ethoxy)methyl)-1H-1,2,3-
triazole (4a). White solid (0.50 g, 80%); mp 121–122 C,
Rf = 0.21 (n-hexane/EtOAc 1:2), [a]D =+15.4 (c 0.5,
DCM), IR (KBr): 3120, 3088, 2958, 2929, 2860, 1741, 1556,
1458, 1373, 1226, 1219, 1107, 1041, 947, 852, 669, 605 cm1.
1H NMR (400 MHz, CDCl3) d ppm: 0.84 (t, J 6.8 Hz, 3H,
H70), 1.25(m, 8H, H30AH60), 1.84, 2.01, 2.04, 2.05 (s,12H,
ACH3 acetate), 1.87 (m, 2H, H20), 3.00 (t, J 6.5 Hz, 2H, C4tri-
azole1ACH2CH2AO), 3.75 (t, J 6.5 Hz, 2H, C4triazole1ACH2-
CH2AO), 3.99 (ddd, J 10.2, 5.0, 2.1 Hz, 1H, H500), 4.13 (dd,
J 12.6, 2.1 Hz, 1H, Ha600), 4.28 (t, J 7.4 Hz, 2H, H10), 4.30
(dd, J 12.5, 2.7 Hz, 1H, Hb60 0), 4.63 (s, 2H, C4triazole2ACH2-
AO), 5.22 (m, 1H, H40 0), 5.41 (m, 2H, H200, H300), 5.86 (m,
1H, H100), 7.39, 7.75 (s, 2H, H5triazole1, H5triazole2).
13C NMR
(100 MHz, CDCl3) d ppm: 14.1, 20.3, 20.6, 20.62, 20.8, 22.6,
26.5, 28.7, 30.4, 31.6, 50.3, 61.6, 64.2, 67.8, 69.6, 70.4, 72.7,
75.2, 85.8, 121.0, 121.7, 144.9, 145.9, 169.0, 169.4, 170.0,
170.6; HRMS (ESI) calcd for C28H42N6O10Na 645.2855
[M+Na]+, found 645.2847.
2.2.3.2. 1-N-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-4-
(((1-n-octyl-1H-1,2,3-triazol-4-yl)ethoxy)methyl)-1H-1,2,3-
triazole (4b). White solid (0.52 g, 82%); mp 123–124 C,
Rf = 0.21 (n-hexane/EtOAc 1:3), [a]D =+20.1 (c 0.5,
DCM), IR (KBr): 3120, 3084, 2926, 2858, 1740, 1554, 1444,
1371, 1224, 1105, 1041, 923, 846, 682, 603 cm1. 1H NMR
(400 MHz, CDCl3) d ppm: 0.85 (t, J 6.7 Hz, 3H, H80), 1.25
(m, 10H, H30AH70), 1.86, 2.01, 2.05, 2.06 (s, 12H, ACH3 ace-
tate), 1.87 (m, 2H, H20), 3.00 (t, J 6.6 Hz, 2H, C4triazole1ACH2-
CH2AO), 3.76 (t, J 6.6 Hz, 2H, C4triazole1ACH2CH2AO), 3.99
(ddd, J 10.1, 5.0, 2.1 Hz, 1H, H500), 4.14 (dd, J 12.6, 2.1 Hz,
1H, Ha60 0), 4.27 (t, J 7.4 Hz, 2H, H10), 4.31 (dd, J 12.5,
2.7 Hz, 1H, Hb60 0), 4.63 (s, 2H, C4triazole2ACH2AO), 5.22
(m, 1H, H400), 5.40 (m, 2H, H200, H30 0), 5.87 (m, 1H, H10 0),
7.39, 7.75 (s, 2H, H5triazole1, H5triazole2).
13C NMR
(100 MHz, CDCl3) d ppm: 14.1, 20.3, 20.6, 20.62, 20.8, 22.7,
26.56, 26.6, 29.1, 29.12, 30.4, 31.8, 50.3, 61.6, 64.2, 67.8,
69.6, 70.4, 72.7, 75.2, 85.8, 121.0, 121.7, 144.9, 145.9, 169.0,
169.4, 170.0, 170.6; HRMS (ESI) calcd for C29H45N6O10
637.3192 [M+H]+, found 637.3187.Please cite this article in press as: Mohammed, A.I. et al., Synthesis and a
1,2, 3-triazol-4-yl)ethoxymethyl)-1,2,3-triazolesd-glucose –>. Arabian Journ2.2.3.3. 1-N-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)-4-
(((1-n-Decyl-1H-1,2,3-triazol-4-yl)ethoxy)methyl)-1H-1,2,3-
triazole (4c). White solid (0.55 g, 82%); mp 131–133 C,
Rf = 0.20 (n-hexane/EtOAc 1:2), [a]D = +27.7 (c 0.5, DCM),
IR (KBr): 3473, 3120, 3076, 2926, 2858, 1741, 1554, 1456,
1375, 1217, 1105, 1041, 921, 846, 721, 675, 605 cm1. 1H
NMR (400 MHz, CDCl3) d ppm: 0.84 (t, J 6.7 Hz, 3H, H70),
1.24 (m, 14H, H30AH90), 1.84, 2.00, 2.04, 2.06
(s,12H, ACH3 acetate), 1.87 (m, 2H, H20), 3.00 (t, J 6.5 Hz,
2H, C4triazole1ACH2CH2AO), 3.76 (t, J 6.5 Hz, 2H,
C4triazole1ACH2CH2AO), 3.99 (ddd, J 10.2, 5.0, 2.1 Hz, 1H,
H500), 4.14 (dd, J 12.6, 2.1 Hz, 1H, Ha600), 4.27 (t, J 7.2 Hz,
2H, H10), 4.30 (dd, J 12.5, 3.8 Hz, 1H, Hb60 0), 4.63 (s, 2H,
C4triazole2ACH2AO), 5.22 (m, 1H, H40 0), 5.41 (m, 2H, H200,
H300), 5.86 (m, 1H, H100), 7.39, 7.75 (s, 2H, H5triazole1,
H5triazole2).
13C NMR (100 MHz, CDCl3) d ppm: 14.2, 20.3,
20.6, 20.63, 20.8, 22.7, 26.6, 26.61, 29.1, 29.3, 29.5, 29.6, 30.4,
31.9, 50.3, 61.6, 64.2, 67.8, 69.6, 70.4, 72.7, 75.2, 85.8, 121.0,
121.7, 144.9, 145.9, 169.0, 169.5, 170.0, 170.6; HRMS (ESI)
calcd for C31H48N6O10Na 687.3324 [M+Na]
+, found
687.3316.
2.2.3.4. 1-N-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-4-
(((1-n-dodecyl-1H-1,2,3-triazol-4-yl)ethoxy)methyl)-1H-
1,2,3-triazole (4d). White solid (0.58 g, 84%); mp 134–135 C,
Rf = 0.19 (n-hexane/EtOAc 1:2), [a]D =+9.6 (c 0.5, DCM),
IR (KBr): 3477, 3120, 3082, 2924, 2854, 1741, 1552, 1458,
1375, 1224, 1103, 1039, 921, 848, 723, 682, 601 cm1. 1H
NMR (400 MHz, CDCl3) d ppm: 0.85 (t, J 6.7 Hz, 3H, H70),
1.25 (m, 18H, H30AH110), 1.84, 2.01, 2.05, 2.06 (s,12H,
ACH3 acetate), 1.85 (m, 2H, H20), 3.00 (t, J 6.5 Hz, 2H,
C4triazole1ACH2CH2AO), 3.76 (t, J 6.5 Hz, 2H,
C4triazole1ACH2CH2AO), 3.99 (ddd, J 10.2, 5.0, 2.1 Hz, 1H,
H500), 4.14 (dd, J 12.6, 2.1 Hz, 1H, Ha600), 4.27 (t, J 7.2 Hz,
2H, H10), 4.30 (dd, J 12.5, 4.2 Hz, 1H, Hb60 0), 4.63 (s, 2H,
C4triazole2ACH2AO), 5.22 (m, 1H, H40 0), 5.41 (m, 2H, H200,
H300), 5.86 (m, 1H, H100), 7.39, 7.75 (s, 2H, H5triazole1,
H5triazole2).
13C NMR (100 MHz, CDCl3) d ppm: 14.2, 20.3,
20.6, 20.63, 20.8, 22.8, 26.6, 26.61, 29.1, 29.4, 29.5, 29.6,
29.7, 30.4, 40.0, 50.3, 61.6, 64.2, 67.8, 69.6, 70.4, 72.7, 75.2,
85.8, 121.0, 121.7, 144.9, 145.9, 169.0, 169.5, 170.0, 170.6;
HRMS (ESI) calcd for C33H52N6O10Na 715.3637
[M+ Na]+, found 715.3628.
2.2.4. General procedure for deprotection of bistriazoles 4a–d.
Synthesis of compounds (5a–d)
Methanolic NaOMe (0.20 mL, 0.1 mmol, 0.5 M) was added to
a solution of protected bistriazoles 4a–d (0.5 mmol) in anhyd.
MeOH (3 mL). The mixture was stirred for 3 h at rt then
Amberlite IR 120 (H+) resin (0.5 g) was added. The mixture
was allowed to stir until the neutralization occurred (15–
20 min), the resin was ﬁltered off. The ﬁltrate was concentrated
in vacuo to yellow syrup then the residue was dissolved in small
amount of EtOH and triturated with n-pentane to afford the
deprotected bistriazoles 5a–d.
2.2.4.1. 1-N-(b-D-Glucopyranosyl)-4-(((1-n-heptyl-1H-1,2,3-
triazol-4-yl)ethoxy)methyl)-1H-1,2,3-triazole (5a). White so-
lid (0.22 g, 95%); mp 139–141 C, Rf = 0.19 (DCM/MeOH
9:1), [a]D =+39.2 (c 0.1, MeOH), IR (KBr): 3446, 3381,
2954, 2858, 1641, 1554, 1462, 1371, 1224, 1047, 900, 827,ntibacterial activity of 1-N-(b-D-glucopyranosyl)-4-((1-substituted-1H-
al of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.02.016
Synthesis of new ether-linked bis-1,2,3-triazole derivatives based on D-glucose 5765, 584 cm1. 1H NMR (400 MHz, MeOH-d4) d ppm: 0.89 (t,
J 6.7 Hz, 3H, H70), 1.32 (m, 8H, H30AH60), 1.88 (quin, J
7.3 Hz, 2H, H20), 2.96 (t, J 6.5 Hz, 2H, C4triazole1ACH2CH2-
AO), 3.77 (t, J 6.6 Hz, 2H, C4triazole1ACH2CH2AO), 3.48–
3.92 (m, 6H, H50 0, Ha60 0, Hb60 0, H40 0, H300, H20 0), 4.32 (t, J
7.2 Hz, 2H, H10), 4.63 (s, 2H, C4triazole2ACH2AO), 5.62 (d, J
9.2 Hz, 1H, H100), 7.76, 8.17 (s, 2H, H5triazole1, H5triazole2).
13C NMR (100 MHz, MeOH-d4) d ppm: 14.4, 23.6, 27.1,
27.4, 29.7, 31.3, 32.8, 51.3, 62.4, 64.6, 70.2, 70.9, 74.0, 78.4,
81.1, 89.6, 124.0, 124.3, 145.9, 146.1; HRMS (ESI) calcd for
C20H35N6O6 455.2612 [M+ H]
+, found 455.2612.
2.2.4.2. 1-N-(b-D-Glucopyranosyl)-4-(((1-n-octyl-1H-1,2,3-
triazol-4-yl)ethoxy)methyl)-1H-1,2,3-triazole (5b). White so-
lid (0.22 g, 93%); mp 141–143 C, Rf = 0.18 (DCM/MeOH
9:1), [a]D = +44.5 (c 0.1, MeOH), IR (KBr): 3441, 3356,
3142, 2926, 2854, 1641, 1552, 1462, 1373, 1222, 1099, 1049,
900, 827, 765, 732, 603 cm1. 1H NMR (400 MHz, MeOH-
d4) d ppm: 0.89 (t, J 6.8 Hz, 3H, H80), 1.32 (m, 10H,
H30-H70), 1.87 (quin, J 7.4 Hz, 2H, H20), 2.96 (t, J 6.5 Hz,
2H, C4triazole1ACH2CH2AO), 3.77 (t, J 6.5 Hz, 2H,
C4triazole1ACH2CH2AO), 3.48–3.92 (m, 6H, H50 0, Ha600, Hb60 0,
H40 0, H300, H20 0), 4.34 (t, J 7.2 Hz, 2H, H10), 4.63 (s, 2H,
C4triazole2ACH2AO), 5.62 (d, J 9.2 Hz, 1H, H100), 7.76, 8.16
(s, 2H, H5triazole1, H5triazole2).
13C NMR (100 MHz, MeOH-
d4) d ppm: 14.4, 23.7, 27.1, 27.5, 30.0, 30.2, 31.3, 32.9, 51.3,
62.4, 64.6, 70.2, 70.9, 74.0, 78.4, 81.1, 89.6, 124.0, 124.3,
145.9, 146.1; HRMS (ESI) calcd for C21H37N6O6 469.2769
[M+ H]+, found 469.2765.
2.2.4.3. 1-N-(b-D-Glucopyranosyl)-4-(((1-n-decyl-1H-1,2,3-
triazol-4-yl)ethoxy)methyl)-1H-1,2,3-triazole (5c). White so-
lid (0.24 g, 96%); mp 150–152 C, Rf = 0.16 (DCM/MeOH
9:1), [a]D = +12.3 (c 0.1, MeOH), IR (KBr): 3414, 3383,
3142, 2926, 2855, 1637, 1554, 1462, 1371, 1224, 1099, 1049,
900, 825, 765, 721, 599 cm1. 1H NMR (400 MHz,
MeOH-d4) d ppm: 0.90 (t, J 6.6 Hz, 3H, H100), 1.32
(m, 14H, H30AH90), 1.87 (quin, J 7.3 Hz, 2H, H20), 2.96 (t, J
6.5 Hz, 2H, C4triazole1ACH2CH2AO), 3.77 (t, J 6.5 Hz, 2H,
C4triazole1ACH2CH2AO), 3.49–3.92 (m, 6H, H50 0, Ha600, Hb60 0,
H40 0, H300, H20 0), 4.34 (t, J 7.2 Hz, 2H, H10), 4.63 (s, 2H,
C4triazole2ACH2AO), 5.62 (d, J 9.2 Hz, 1H, H100), 7.76, 8.16
(s, 2H, H5triazole1, H5triazole2).
13C NMR (100 MHz,
MeOH-d4) d ppm: 14.5, 23.7, 27.1, 27.5, 30.1, 30.4, 30.55,
30.6, 31.3, 33.0, 51.3, 62.4, 64.6, 70.2, 70.8, 74.0, 78.4, 81.1,
89.6, 124.0, 124.3, 145.9, 146.0; HRMS (ESI) calcd for
C23H41N6O6 497.3082 [M+ H]
+, found 497.3080.
2.2.4.4. 1-N-(b-D-Glucopyranosyl)-4-(((1-n-dodecyl-1H-1,2,3-
triazol-4-yl)ethoxy)methyl)-1H-1,2,3-triazole (5d). White so-
lid (0.24 g, 91%); mp 155–156 C, Rf = 0.15 (DCM/MeOH
9:1), [a]D = +19.8 (c 0.1, MeOH), IR (KBr): 3506, 3387,
3134, 2922, 2854, 1556, 1463, 1373, 1321, 1228, 1103, 1043,
900, 833, 721, 621, 588 cm1. 1H NMR (400 MHz,
MeOH-d4) d ppm: 0.90 (t, J 6.6 Hz, 3H, H120), 1.32 (m,
18H, H30AH110), 1.87 (quin, J 7.3 Hz, 2H, H20), 2.96 (t, J
6.5 Hz, 2H, C4triazole1ACH2CH2AO), 3.77 (t, J 6.5 Hz, 2H,
C4triazole1ACH2CH2AO), 3.48–3.92 (m, 6H, H50 0, Ha600, Hb60 0,
H40 0, H300, H20 0), 4.34 (t, J 7.2 Hz, 2H, H10), 4.63 (s, 2H,
C4triazole2ACH2AO), 5.62 (d, J 9.2 Hz, 1H, H100), 7.75, 8.16
(s, 2H, H5triazole1, H5triazole2).
13C NMR (100 MHz,
MeOH-d4) d ppm: 14.5, 23.7, 27.1, 27.5, 30.1, 30.5, 30.6,Please cite this article in press as: Mohammed, A.I. et al., Synthesis and a
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81.1, 89.6, 124.0, 124.3, 145.9, 146.1; HRMS (ESI) calcd for
C25H45N6O6 525.3395 [M+H]
+, found 525.3393.
2.3. Biological screening (Jayanna et al., 2012)
The antibacterial efﬁcacy of the synthesized compounds was
tested against Gram positive bacteria S. aureus and Gram neg-
ative bacteria E. coli by the agar well diffusion method.
Twenty four old Muller–Hinton broth cultures of test bacte-
ria were swabbed on sterile Muller–Hinton agar plates using
sterile cotton swab followed by punching wells of 6 mm with
the help of sterile cork borer. 20 mg/mL in 10% DMSO and
control (10% DMSO) were added to respectively labeled wells.
The plates are allowed to stand for 30 min and were incubated
at 37 C for 24 h in upright position and the zone of inhibition
was recorded.3. Results and discussion
3.1. Synthesis
Alkyl azides 1a–d were converted to the corresponding triazol-
yl alcohols 2a–d in approximately excellent yields via click
protocol. Proton NMR spectra of compounds 2a–d showed
a clear signal at 7.37 ppm which attributed to the H5 of the
triazole ring. In addition, the signals at 121.5 ppm C5 and
146.5 ppm C4 in 13C NMR spectra provided an excellent evi-
dence for triazoles formation. The following scheme describes
the overall synthetic route of the targeted compounds:
The subsequent step was Williamson etheriﬁcation of
compounds 2a–d using propargyl bromide and NaOH as het-
erogeneous catalysts. Compounds 3a–d were isolated in very
good yields 80–86% and the formation of alkynyl triazoles
was investigated by the appearance of the triplet acetylenic
signals between 2.38 and 2.42 ppm and the doublet between
4.11 and 4.20 ppm that attributed to the methylene group
OACH2AC„CH. Furthermore, three important signals that
appeared in the 13C NMR spectra of compounds 3a–d
supported the formation of the alkynyl triazoles. The ﬁrst
one appeared around 50.3 ppm referred to the methylene car-
bon OACH2AC„CH. The second signal at 74.5 ppm assigned
the terminal acetylenic carbon while the third signal allocated
the quaternary acetylenic carbon at 79.8 ppm.
The readily available 2,3,4,6-tetra-O-acetyl-b-D-glucopyr-
anosyl azide has been used as a precursor of bis-1,2,3-triazoles
4a–d. Cu(I) catalyzed 1,3-dipolarcycloaddition reaction
between alkynyl triazoles 3a–d and 2,3,4,6-tetra-O-acetyl-b-D-
glucopyranosyl azide afforded compounds 4a–d in very good
yields 80–84%. The structures of these compounds were also
determined by NMR spectroscopy in addition to the other
techniques. Owing to facilitate the explanation of NMR spec-
tra, numbering of compound 4a is shown below:
Beside the sugar signals, there was an important singlet at
7.75 ppm which clearly referred to the H5 of triazole 2. In
the same way, 13C NMR spectra supported the structures of
bistriazoles. The signals at 121.0 and 145.9 ppm, for example;
were attributed to the C5 and C4 of triazole heterocycle 2,
respectively. All assignments of proton and carbon NMR were
based on COSY and HSQC. The acetate groups of glucose
moiety were removed readily by treating compounds 4a–d withntibacterial activity of 1-N-(b-D-glucopyranosyl)-4-((1-substituted-1H-
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Table 1 Antibacterial activity of the synthesized bis-1,2,3-triazoles.
Compound Zone of inhibition in (mm), concentration (lg/mL)
G+ Staphylococcus aureus G Escherichia coli
5 10 20 5 10 20
DMSO – – – – – –
Kanamycin 27 28 28 28 27 28
4a – 03 05 – 02 05
4b – 05 11 – 06 11
4c – 05 11 – 06 12
4d – 04 08 – 03 05
5a – 05 11 – 04 07
5b – 06 13 – 05 11
5c – 06 12 – 05 10
5d – 05 07 – 04 09
6 A.I. Mohammed et al.sodium methoxide in order to give the corresponding com-
pounds 5a–d. The disappearance of the methyl group signals
in 1H and 13C NMR spectra and the other signals of the
C‚O group are evident proof for the deprotection.
3.2. Antibacterial activity
The antibacterial activity of the synthesized bistriazoles was
tested against Gram positive bacteria S. aureus and Gram neg-
ative bacteria E. coli by the agar well diffusion method. DMSO
was considered as control while kanamycin was used as
standard. It is shown from Table 1 that both protected and
deprotected bistriazoles did not give any activity at the concen-
tration 5 lg/mL compared to kanamycin. In contrast, all the
mentioned compounds exhibited low to moderate activity at
the concentrations 10 and 20 lg/mL respectively. On the other
hand, the protected and deprotected compounds with C8 and
C10 in the aliphatic chain exhibited maximum antibacterial
activity compared to the other measured compounds. The
antibacterial activity of bistriazoles can be attributed to their
behavior as glycolipids mimics (Treyvaud et al., 2011), biosur-
factants analogs (Ahimou et al. 2000), the asymmetrical struc-
ture of the whole molecule or the protein-binding properties
(Banday et al., 2012).
4. Conclusion
In conclusion, this research has developed a convenient strat-
egy for the synthesis of novel biologically important bis-
1,2,3-triazoles based on D-glucose using copper catalyzed
‘click’ protocol. The obtained products thus were found to
be slight antibacterial agents in two concentrations.
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